CRISPR Therapeutics AG Sustainability Reports
CRISPR Therapeutics AG is a gene-editing company focused on developing transformative, genome-directed medicines for serious human diseases using its proprietary CRISPR/Cas9 platform.
Sector: Professional & technical services
Country: Switzerland
Exchange: Nasdaq
LEI: 506700O6IRRIQLT3W370
FIGI: BBG00DBBGRY0
9 reports from 2016 to 2025
